Li-Fraumeni syndrome: report of a clinical research workshop and creation of a research consortium
about
A systematic review of approaches for engaging patients for research on rare diseasesp53 modulates Hsp90 ATPase activity and regulates aryl hydrocarbon receptor signaling.Tumor protein p53 (TP53) testing and Li-Fraumeni syndrome : current status of clinical applications and future directions.Whole-genome sequencing analysis of phenotypic heterogeneity and anticipation in Li-Fraumeni cancer predisposition syndrome.Fourth primary malignant tumor in a patient with possible li-fraumeni syndrome: synchronous diagnosis of postirradiation sarcoma, cutaneous relapse of a previous soft tissue sarcoma, and lung adenocarcinoma.Emerging Concepts in Breast Cancer Risk Prediction.Multiplex genetic cancer testing identifies pathogenic mutations in TP53 and CDH1 in a patient with bilateral breast and endometrial adenocarcinoma.Germline TP53 mutational spectrum in French Canadians with breast cancer.Reduced life expectancy seen in hereditary diseases which predispose to early-onset tumors.Update on pediatric cancer predisposition syndromes.Syndrome-associated soft tissue tumours.Li-Fraumeni syndrome: cancer risk assessment and clinical management.Germline TP53 mutations and the changing landscape of Li-Fraumeni syndrome.Further evidence for pathogenicity of the TP53 tetramerization domain mutation p.Arg342Pro in Li-Fraumeni syndrome.Baseline Surveillance in Li-Fraumeni Syndrome Using Whole-Body Magnetic Resonance Imaging: A Meta-analysis.Cancer Screening and Early Detection in the 21st Century.Li-Fraumeni syndrome: a paradigm for the understanding of hereditary cancer predisposition.Inherited TP53 Mutations and the Li-Fraumeni Syndrome.Easing the Burden: Describing the Role of Social, Emotional and Spiritual Support in Research Families with Li-Fraumeni Syndrome.Allele-specific wild-type TP53 expression in the unaffected carrier parent of children with Li-Fraumeni syndrome.Importance of updating family cancer history in childhood cancer survivors.Exploring patient and family involvement in the lifecycle of an orphan drug: a scoping review.Whole body magnetic resonance imaging (WB-MRI) and brain MRI baseline surveillance in TP53 germline mutation carriers: experience from the Li-Fraumeni Syndrome Education and Early Detection (LEAD) clinic.International survey of awareness of genetic risk in the clinical sarcoma community.Pediatric High Grade Gliomas in the Context of Cancer Predisposition Syndromes.Li-Fraumeni Syndrome
P2860
Q26822274-AC65D8E4-4EFA-47E6-8E31-4029BE379CBBQ33819326-7DBB8967-F5EA-4141-8FD1-DE9102F838E1Q34324683-724AF804-981C-400C-8855-41105658F9CFQ34442133-1C88D073-5862-488C-A5A6-FA2237FCAD2AQ34611201-34AE83C1-A183-4876-8F05-1A3ABAA362E3Q34670325-4FBB2AC6-6115-4F87-9FB3-D8B04E6E8265Q35077001-F8CBFBA8-2406-4D23-A227-76B57376077EQ35618321-4E3378B3-5C9F-4D5F-A6DC-B81D66CA8C20Q37074281-F9757E67-62A6-4F7C-B571-01EEB658D3D5Q38102639-EF1F063D-BDC6-47C1-B167-EBDDBA313646Q38162895-DE385603-A9B5-4803-AD5C-E9896C13FB54Q38197030-F40BD7F5-8305-49A3-8198-390A3CB7370DQ38202612-378CEF7B-DE13-4856-BC34-FC63A41AA617Q38250144-5CEF8A65-2764-4A8D-A9A5-203BFA89D0F1Q38643830-80D9B8A6-005C-4FE9-A4E5-DDD5C4218674Q38875555-7E259A1F-E5C8-43CC-BA1E-BBED4C372584Q39041480-C14F5C8B-9A5E-4282-A75F-90E5D4C38C3DQ39167055-AD290A93-22BE-495D-8801-1D1332C7C0D7Q39284496-EB300B8A-F306-464A-85F6-05CC96665B8FQ42775929-A7BA27E4-C0AD-4818-BBFD-CB714A8E31B7Q44931397-774C41D2-962E-420F-BDE0-45D24786A983Q47159898-FA61EDCC-7B8D-4A7F-A433-D63EF0AD4F31Q47617200-147A026F-DFAB-4B71-A305-82AB6B46C038Q48858319-C3E4A715-A63E-47DB-8BAE-B56325734186Q55277238-4093616E-651E-409D-B11B-70DDA4BCA5F9Q58585566-9680D185-6595-477A-ABA2-5AE72357CE0A
P2860
Li-Fraumeni syndrome: report of a clinical research workshop and creation of a research consortium
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Li-Fraumeni syndrome: report o ...... ation of a research consortium
@ast
Li-Fraumeni syndrome: report o ...... ation of a research consortium
@en
type
label
Li-Fraumeni syndrome: report o ...... ation of a research consortium
@ast
Li-Fraumeni syndrome: report o ...... ation of a research consortium
@en
prefLabel
Li-Fraumeni syndrome: report o ...... ation of a research consortium
@ast
Li-Fraumeni syndrome: report o ...... ation of a research consortium
@en
P2093
P2860
P50
P1433
P1476
Li-Fraumeni syndrome: report o ...... ation of a research consortium
@en
P2093
Andrea Patenaude
Benjamin Wilfond
Eveline Bleiker
Ingrid M Wentzensen
Joseph F Fraumeni
Joshua D Schiffman
Judy E Garber
June A Peters
Katherine Schneider
Louise C Strong
P2860
P304
P356
10.1016/J.CANCERGEN.2012.06.008
P50
P577
2012-08-29T00:00:00Z